PROJECT SUMMARY
Old age and obesity are prevalent risk factors for morbidity and mortality. Weight loss (WL) ameliorates many
clinical consequences of obesity; yet despite its benefits, recommendation of intentional WL in older adults
remains controversial. Reluctance stems, at least in part, from loss of bone mass known to accompany overall
WL and the potential for exacerbation of age-related risk of osteoporosis and fracture. Addition of resistance
exercise training (RT) to WL is an effective means to attenuate, but not stop, WL-associated reductions in bone
mineral density (BMD); however, conventional RT interventions present barriers to long term feasibility (i.e.,
expensive equipment, on-site participation, safety supervision by trained staff, and waning compliance).
Alternately, treating the WL-associated decrease in mechanical stress by replacing lost weight externally may
also preserve bone mass. Pilot data from our institution signal that weighted vest use (designed to mimic
weight stability) during WL is both feasible and likely efficacious in reducing WL-associated hip BMD loss while
increasing biomarkers of bone formation. If confirmed, the greater availability, ease of administration, and
reduced cost of weighted vest use to offset WL-associated bone loss, as compared to RT, holds significant
public health potential as a translatable strategy to maximize the cardiometabolic benefits of WL, while
minimizing negative implications for the musculoskeletal system. The main goal of the proposed R01 study is
to compare the effects of WL alone and with weighted vest use or RT on several indicators of bone health and
subsequent fracture risk. We propose a 12 month trial in 192 older (65-79 years) adults with obesity (BMI=30-
40 kg/m2) randomized to one of three interventions (n=64/group): WL alone (WL; caloric restriction targeting
10% WL and following national obesity treatment guidelines); WL plus weighted vest use (WL+VEST; ≥6
hours/day, weight replacement titrated up to 10% WL); or, WL plus structured RT (WL+RT; 3 days/week, 10
exercises, 10-12 repetitions). Our primary study outcome is 12 month change in total hip trabecular volumetric
BMD (vBMD) and we hypothesize that despite similar reductions in total body weight: (1) participants in the
WL+VEST group will show attenuated losses of total hip trabecular vBMD versus WL, and (2) loss in total hip
trabecular vBMD will be no greater in WL+VEST compared to WL+RT. Led by a talented New Investigator, this
proposal is a natural extension of the work accomplished during the PI’s current MRSDA (K01 AG047291), and
confers public health impact by testing a translatable strategy aimed at optimizing intentional WL in older adults
with obesity while elucidating mechanisms governing musculoskeletal response to WL.